Header Logo



This is a "connection" page, showing publications co-authored by Carl Maki and Jeffrey Borgia.
Connection Strength

  1. Prolyl Carboxypeptidase Maintains Receptor Tyrosine Kinase Signaling and Is a Potential Therapeutic Target in Triple Negative Breast Cancer. Cancers (Basel). 2022 Jan 31; 14(3).
    View in: PubMed
    Score: 0.212
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.